SCHEMBL7344228

SCHEMBL7344228

Nc1cccc2c1NCC(NC(=O)O)C2

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.41
MAPK1 P28482 1/20 0.38
HDAC8 Q9BY41 5/20 0.36
GRM7 Q14831 2/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
ACHE P22303 1/20 0.34
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
CRBN Q96SW2 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
PYGL P06737 1/20 0.32
PYGM P11217 1/20 0.32
HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7001370 0.83 AURKA (0.40) EPHX2MAPK1HDAC8GRM7NPC1
SCHEMBL2840737 0.76 PYGL (0.42) CRBNKDM4EPYGLPYGM
SCHEMBL429344 0.76 EPHX2 (0.66) EPHX2MAPK1HDAC8GRM7MTNR1A
SCHEMBL7797306 0.72 MEN1 (0.36) LMNAKDM4EMAPT
SCHEMBL2845844 0.72 DRD2 (0.39) LMNAKDM4EMAPT
SCHEMBL9851524 0.70 GRM7 (0.59) GRM7CA1CA2MTNR1AMTNR1B
SCHEMBL22469548 0.70 GRM7 (0.44) EPHX2GRM7MTNR1AMTNR1BNPC1
SCHEMBL7694131 0.70 GRM7 (0.44) EPHX2GRM7MTNR1AMTNR1BNPC1
SCHEMBL7344883 0.69 EPHX2 (0.30) EPHX2
SCHEMBL28909950 0.69 MTNR1A (0.35) MTNR1AMTNR1BHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed